""

  • : 229


INTENDIS (DEU)◊ /. . 0.1%: 15
INTENDIS MANUFACTURING (ITA)◊ /. . 0.1%: 15
INTENDIS (DEU)◊ /. . 0.1%: 15 50
INTENDIS MANUFACTURING (ITA)◊ /. . 0.1%: 15 50
INTENDIS (DEU)◊ /. . 0.1%: 15
INTENDIS MANUFACTURING (ITA)◊ /. . 0.1%: 15
INTENDIS (DEU)◊ /. . 0.1%: 20
INTENDIS MANUFACTURING (ITA)◊ /. . 0.1%: 20
®- (RUS)◊ /. . 0.064%: 15 30
®- (RUS)◊ /. . 0.064%: 15 30
SCHERING-PLOUGH LABO (BEL) . 50 /1 : 200 (8.5 )
®BELUPO Pharmaceuticals & Cosmetics (HOR)◊ /. . 0.05%: 20 40
®BELUPO Pharmaceuticals & Cosmetics (HOR)◊ /. . 0.05%: 20 40
NORTON WATERFORD (IRL) /. . 50 /1 : 200
NORTON WATERFORD (IRL) /. . 100 /1 : 200
NORTON WATERFORD (IRL) /. . 250 /1 : 200
NORTON WATERFORD (IRL) /. , , 50 /1 : 200
NORTON WATERFORD (IRL) /. , , 250 /1 : 200
NORTON WATERFORD (IRL) /. , , 100 /1 : 200
CIPLA (IND) /. . 400 : 30 .
CIPLA (IND) /. . 50 /1 : 200
CIPLA (IND) /. . 100 /1 : 200
CIPLA (IND) /. . 200 /1 : 200
CIPLA (IND) /. . 250 /1 : 200
® 250CHIESI (FRA)- /. 250 /1 : . 200
GLAXO WELLCOME (SPN) . 50 /1 : . 100 200
GlaxoSmithKline Consumer Healthcare (SPN) . 50 /1 : . 100 200
GLAXO WELLCOME PRODUCTION (FRA) . /. 50 /1 : 200
GLAXO WELLCOME PRODUCTION (FRA) . /. 250 /1 : 200
®BELUPO Pharmaceuticals & Cosmetics (HOR)◊ /. . 0.05%: 15 30
®BELUPO Pharmaceuticals & Cosmetics (HOR)◊ /. . 0.05%: 15 30
® (RUS)- /. 250 /1 : . 2.2 10 .
® (RUS) /. 200 /1 : "" 100 200
® (RUS)- /. 500 /1 : . 2.2 10 .
(RUS) 0.05%: . 5 10 , .- 5 10
®BERLIN-CHEMIE AG/MENARINI GROUP (DEU). 4 : 25 .
® (RUS) / 0.1%: . 5 . -.
® (RUS) / 0.1%: . 5 . -.
DAROU PAKHSH PHARMACEUTICAL MFG. COMPANY (IRA) 0.1%: . 5
- (RUS)- // / 4 /1 : . 1 .
GlaxoSmithKline Pharmaceuticals (IND)◊ /. . 0.1% (1 /1 ): 20
-IVAX Pharmaceuticals UK LTD () 2 0,5/ 5
-IVAX Pharmaceuticals UK LTD () 2 0,25 / 5
Dr. FALK PHARMA (DEU). 3 : 20 .
LOSAN PHARMA (DEU). 3 : 20 .
ORION CORPORATION ORION PHARMA (FIN) /. 200 /1 : 200
-DAROU PAKHSH PHARMACEUTICAL MFG. COMPANY (IRA)- /. 4 /1 : . 5 .
- (RUS)- /. 4 /1 : . 5 10 .
- (RUS)◊ /. . 1%: 10
PHARMACEUTICAL WORKS JELFA (POL)◊ 0.5%: 3
(RUS)◊ /. . 1%: 10
HEMOFARM KONCERN (UGS). /. - /. 100 : . 1 . .
HEMOFARM KONCERN (UGS). /. - /. 500 : . 1 . .
(UKR). // 25 /1 : . 5 10 .
(UKR). // 50 /2 : . 5 10 .
(RUS)◊ /. . 1%: 10
(RUS) 0.5%: 3
(RUS) 0.5%: 3 5
(RUS)◊ /. . 1%: 10
(RUS)◊ /. . 1%: 10
(RUS)◊ /. . 1%: 10
- (RUS)◊ 1%: 10
-URSAPHARM ARZNEIMITTEL (DEU)◊ 1%: 2.5
-URSAPHARM ARZNEIMITTEL (DEU)◊ 2.5%: 2.5
-GEDEON RICHTER (HUN). /. 125 +25 /5 : . 1 .
GALENIKA (SCH). 500 : 50 .
GALENIKA (SCH)- /. 4 /1 : . 5 .
DAROU PAKHSH PHARMACEUTICAL MFG. COMPANY (IRA) 0.1%: -. 5
MEDOCHEMIE (KIP)- // / . 4 /1 : . 100 .
MEDOCHEMIE (KIP)- // / . 8 /2 : . 100 .
KRKA (SLO). 500 : 10 .
KRKA (SLO)- /. 4 /1 : . 25 .
- (RUS). 500 : 50 .
WARSAW PHARMACEUTICAL WORK POLFA (POL) 1 /1 : - 5
M.J.BIOPHARM (IND)- /. 4 /1 : . 5, 10, 15, 20 25 .
M.J.BIOPHARM (IND)- /. 8 /2 : . 5, 10, 15, 20 25 .
SHREYA LIFE SCIENCES (IND)- /. 4 /1 : . 25 . . 25 .
(RUS)- /. 4 /1 : . 5 10 .
(UKR) 0.1%: . 5 10
(UKR). 500 : 50 .
- - - (RUS)- /. 4 /1 : . 5 10 .
- - - (RUS)- /. 8 /2 : . 5 10 .
S.C. ROMPHARM Company (RUM) 0.1%: .-. 10
(RUS)- /. 4 /1 : . 10 .
(RUS)- /. 8 /2 : . 10 .
- (RUS). 500 : 50 .
NYCOMED AUSTRIA (AUT)- /. 4 /1 : . 1, 5 25 .
-- (RUS) 0.1%: .-. 10
-- (RUS) 0.1%: . 5 10
-- (RUS). 500 : 10, 20 50 .
-- (RUS)- /. 4 /1 : . 5 .
-- (RUS)- /. 8 /2 : . 5 .
URSAPHARM ARZNEIMITTEL (DEU) 0.1%: .-. 5
FARAN LABORATORIES (GR)- /. 4 /1 : . 4 .
-CADILA HEALTHCARE (IND). 500 : 100 .
-CADILA HEALTHCARE (IND)- /. 4 /1 : . 5 .
-CADILA HEALTHCARE (IND)- /. 8 /2 : . 6 .
-®PFIZER MFG. BELGIUM (BEL). /. 40 /1 : . 1 .
GlaxoSmithKline Pharmaceuticals (POL) /. . 500 /1 : 25
GlaxoSmithKline Pharmaceuticals (POL) /. . 500 /1 : 25
GLAXO OPERATIONS UK LIMITED (GBR) /. . 500 /1 : 25
GLAXO OPERATIONS UK LIMITED (GBR) /. . 500 /1 : 25
(RUS)- /. 4 /1 : . 5, 10 25 .
SCHERING-PLOUGH LABO (BEL). /. 2 +5 /1 : . 1 5 .
KRKA (SLO). 4 : 50 .
BRISTOL-MYERS SQUIBB (ITA). /. 40 /1 : . 5 .
40KRKA (SLO). /. 40 /1 : . 5 .
®CHIESI FARMACEUTICI (ITA)- /. 50 /1 : 200
®CHIESI FARMACEUTICI (ITA)- /. 250 /1 : 200
®CHIESI FARMACEUTICI (ITA)- /. . 50 /1 : 200
®CHIESI FARMACEUTICI (ITA)- /. . 250 /1 : 200
PHARMACIA & UPJOHN COMPANY (USA). 5 : 50 .
PATHEON WHITBY (CAN). 5 : 50 .
PHARMACIA & UPJOHN COMPANY (USA). 10 : 100 .
PATHEON WHITBY (CAN). 10 : 100 .
PHARMACIA & UPJOHN COMPANY (USA). 20 : 100 .
PATHEON WHITBY (CAN). 20 : 100 .
GlaxoSmithKline Pharmaceuticals (POL) /. . 500 /1 : 15
GlaxoSmithKline Pharmaceuticals (POL) /. . 50 /1 : 15
PHARMACEUTICAL WORKS JELFA (POL)◊ 0.1%: 15
PHARMACEUTICAL WORKS JELFA (POL)◊ 0.1%: 15
PHARMACEUTICAL WORKS JELFA (POL)◊ - /. . 0.1%: . 20
®HEMOFARM (RS) /. - // / 125 : . .
®HEMOFARM (RS). 4 : 20 .
®YAMANOUCHI EUROPE (NID)◊ /. . 0.1%: 30
®YAMANOUCHI PHARMA (ITA)◊ /. . 0.1%: 30
ALCON-COUVREUR (BEL) 0.1%: 3.5
ALCON-COUVREUR (BEL).- 0.1%: .-. 5
MEDOCHEMIE (KIP)- // / 30 /1 : . 10 100 .
®PHARMACIA (BEL). 4 : 10, 30 100 .
®PHARMACIA ITALIA (ITA). 4 : 10, 30 100 .
®PHARMACIA (BEL). 16 : 14 50 .
®PHARMACIA ITALIA (ITA). 16 : 14 50 .
®PHARMACIA (BEL). 32 : 20 50 .
®PHARMACIA ITALIA (ITA). 32 : 20 50 .
SOPHARMA (BLG) /. - // / . 8 : . 10 . .
SOPHARMA (BLG) /. - // / . 20 : . 10 . .
SOPHARMA (BLG) /. - // / . 40 : . 10 . .
ORION CORPORATION (FIN). 4 : 30 100 .
ORION CORPORATION (FIN) /. - // / 250 : . 1 . .
ORION CORPORATION (FIN). 16 : 30 100 .
GLENMARK PHARMACEUTICALS (IND) /. . 0.1%: 5 15
GLENMARK PHARMACEUTICALS (IND) /. . 0.1%: 5
IVAX Pharmaceuticals (CS) . 50 /1 : . 60, 120 150
®SCHERING-PLOUGH LABO (BEL) 50 /1 : . 120
IVAX Pharmaceuticals (CS) . 50 /1 : . 200
NORTON HEALTHCARE (GBR) /. . 50 /1 : . 100 180
® SANTEN (FIN) 0.1%: .- 5
Pharmaceutical Works Polfa in Pabianice (POL). 4 : 50 .
IPCA LABORATORIES (IND). 5 : 100 .
IPCA LABORATORIES (IND)- /. 30 /1 : . 3 .
- (RUS). 5 : 100 .
Pharmaceutical Works Polfa in Pabianice (POL). 5 : 30 .
GEDEON RICHTER (HUN). 5 : 100 .
GEDEON RICHTER (HUN)- /. 30 /1 : . 3 .
(RUS) /. . 0.5%: 10
M.J.BIOPHARM (IND). 5 : 100 .
M.J.BIOPHARM (IND)- /. 30 /1 : . 3 .
. .. (RUS) /. - /. 25 : . 5 .
(RUS) /. . 0.5%: 10 15
(RUS) /. . 0.5%: 10 15
PHARMEDGE LIFE SCIENCE (IND)- /. 30 /1 : . 3 .
(RUS)- /. 30 /2 : . 3 5 .
(RUS). 5 : 30, 60, 100 120 .
(RUS)- // / 30 /1 : .
(RUS)- // / 30 /1 : .
(RUS). 5 : 100 .
SIMPEX PHARMA (IND). 5 : 100 .
SIMPEX PHARMA (IND)- // / 30 /1 : . 10 .
(RUS). 5 : 20 .
(RUS). 1 : 20 .
- (RUS). 5 : 120 .
(RUS) /. . 0.5%: 10
NYCOMED AUSTRIA (AUT). 5 : 30 .
NYCOMED AUSTRIA (AUT)- // / 25 /1 : . 3, 25, 50 100 .
- (RUS) 0.5%: 10 15
-- (RUS) /. . 0.5%: 10 15
- (RUS) /. - /. 25 : . 5 .
S.I.F.I. (ITA) 0.25%: . 10 1 . .
ZAMBON (ITA) 0.25%: . 10 1 . .
S.I.F.I. (ITA) 0.25%: 10 1 .
ZAMBON (ITA) 0.25%: 10 1 .
®ASTRAZENECA (SWE). /. 500 /2 : 20 .
®ASTRAZENECA (SWE). /. 1 /2 : 20 .
® ®ASTRAZENECA (SWE) /. . 100 /1 : 200
® ®ASTRAZENECA (SWE) /. . 200 /1 : 100 200
CHIESI FARMACEUTICI (ITA) . 770 /1 : . 120 200
- (RUS) /. . 0.025%: 10
(RUS) /. . 0.025%: 10 15
(RUS) 0.025%: 15
- (RUS) /. . 0.025%: 10 15
(RUS) /. . 0.025%: 15
- (RUS) /. . 0.025%: 10 15
GALENIKA (SCH) /. . 0.025%: 30
GALENIKA (SCH) /. . 0.025%: 30
GALENIKA (SCH) /. . 0.025%: 30
-®PHARMACIA (BEL) /. - /. 40 : .
-®PHARMACIA (BEL) /. - /. 125 : .
-®PHARMACIA (BEL) /. - /. 250 : .
-®PHARMACIA (BEL) /. - /. 500 : . .
-®PHARMACIA (BEL) /. - /. 1 : . .
PHARMACEUTICAL WORKS JELFA (POL)- /. 100 /2 : . 5 . .
® LEK d.d. (SLO) 50 /1 : . 200
® LEK d.d. (SLO) /. . 200 /1 : 200 ( )
® SOFOTEC (DEU) /. . 200 /1 : 200 ( )
- (RUS) /. . 0.1%: 10
- (RUS) /. . 0.1%: 15 30
ALCON-COUVREUR (BEL).- 0.1%: .-. 5
GlaxoSmithKline Pharmaceuticals (POL) . 50 /1 : . 60 120
GlaxoSmithKline Pharmaceuticals (POL) /. 50 /1 : 60 120
GlaxoSmithKline Pharmaceuticals (POL) /. 125 /1 : 60 120
GlaxoSmithKline Pharmaceuticals (POL) /. 250 /1 : 60 120
KRKA (SLO). /. 2 +5 /1 : . 5 .
- (RUS) /. . 0.025%: 10 15
PHARMACEUTICAL WORKS JELFA (POL) 0.025%: 15
PHARMACEUTICAL WORKS JELFA (POL) 0.025%: 15
GEDEON RICHTER (HUN)◊ /. . 0.1%: 15
-SCHERING-PLOUGH LABO (BEL)◊ /. . 0.1%: 15 30
-SCHERING-PLOUGH LABO (BEL)◊ /. . 0.1%: 15 30
SCHERING-PLOUGH LABO (BEL)- /. 4 /1 : . 5 .
SCHERING-PLOUGH LABO (BEL). 500 : 30 .
TEVA Pharmaceutical Industries (ISR) /. . 400 : 30 .
TEVA Pharmaceutical Industries (ISR) /. . 200 : 30, 60 120 .
TEVA Pharmaceutical Industries (ISR) /. . 100 : 30, 60 120 .
TEVA Pharmaceutical Industries (ISR) /. 200 : 30, 60, 100 120 .
®SCHERING-PLOUGH LABO (BEL) /. . 0.1%: 15 30
®SCHERING-PLOUGH LABO (BEL) 0.1%: . 20
®SCHERING-PLOUGH LABO (BEL) /. . 0.1%: 15 30
® SCHERING-PLOUGH (ITA)- /. . 0.1%: .-. 20